Mesenchymal stem cell-derived exosomes: Toward cell-free therapeutic strategies in regenerative medicine

World J Stem Cells. 2020 Aug 26;12(8):814-840. doi: 10.4252/wjsc.v12.i8.814.

Abstract

Mesenchymal stem cells (MSCs) are multipotent stem cells with marked potential for regenerative medicine because of their strong immunosuppressive and regenerative abilities. The therapeutic effects of MSCs are based in part on their secretion of biologically active factors in extracellular vesicles known as exosomes. Exosomes have a diameter of 30-100 nm and mediate intercellular communication and material exchange. MSC-derived exosomes (MSC-Exos) have potential for cell-free therapy for diseases of, for instance, the kidney, liver, heart, nervous system, and musculoskeletal system. Hence, MSC-Exos are an alternative to MSC-based therapy for regenerative medicine. We review MSC-Exos and their therapeutic potential for a variety of diseases and injuries.

Keywords: Cell-free therapy; Exosomes; Extracellular vesicles; Mesenchymal stem cell-derived exosomes; Mesenchymal stem cells; Regenerative medicine.

Publication types

  • Review